2018-05-07 |
1 |
Complaint |
of
Vanda’s U.S. Patent Nos. RE46,604 (“the RE604 patent”); 9,060,995 (“the ’995 patent”);
9,539,234 (… V. THE PATENTS-IN-SUIT
(U.S. PATENT NOS. RE46,604; 9,060,995; 9,539,234; 9,549,913;… U.S. Patent No. 9,060,995
41. Vanda is the owner… (“the ’234 patent”); 9,549,913 (“the ’913 patent”); 9,730,910 (“the ’910 patent”); and
9,855,241 (“the…“the ’241 patent”) (collectively “the Asserted Patents”), which, in relevant part,
generally relate to |
External link to document |
2019-12-03 |
118 |
Notice of Service |
U.S. Patent No. 10,071,977; (2) Defendants' Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829…
7 May 2018
1:18-cv-00689
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-12-19 |
120 |
Notice of Service |
Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock…
7 May 2018
1:18-cv-00689
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-12-23 |
122 |
Notice of Service |
Invalidity Contentions Concerning U.S. Patent No. 10,071,977 2) Defendants Second Amended Invalidity …Invalidity Contentions Regarding U.S. Patent No. 10,149,829 3) Defendants Third Amended Invalidity Contentions …
7 May 2018
1:18-cv-00689
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-01-30 |
124 |
Notice of Service |
Regarding Infringement by Apotex of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Jacobs…
7 May 2018
1:18-cv-00689
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-02-03 |
125 |
Notice of Service |
Report of Dr. Robert B. Perni Regarding U.S. Patent No. 10,071,977 (2) First Expert Report of Dr. Jonathan …
7 May 2018
1:18-cv-00689
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |